← Evidence map

ReviewInternational journal of molecular sciences2021

Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma.

Corrado Pelaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33922072